United States - English - NLM (National Library of Medicine)

alvogen inc. - melphalan (unii: q41or9510p) (melphalan - unii:q41or9510p) - melphalan 2 mg - melphalan tablets usp are indicated for the palliative treatment of multiple myeloma and for the palliation of non-resectable epithelial carcinoma of the ovary. melphalan tablets usp should not be used in patients whose disease has demonstrated a prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspen pharma trading ltd - melphalan - oral tablet - 2mg

Canada - English - Health Canada

taro pharmaceuticals inc - melphalan (melphalan hydrochloride); buffer solution - kit - 50mg; 10ml - melphalan (melphalan hydrochloride) 50mg; buffer solution 10ml - antineoplastic agents

United States - English - NLM (National Library of Medicine)

par pharmaceutical, inc. - melphalan (unii: q41or9510p) (melphalan - unii:q41or9510p) - melphalan 50 mg in 10 ml - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan 50 mg in 10 ml - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent.  patients who have demonstrated hypersensitivity to melphalan should not be given the drug.

Israel - English - Ministry of Health

padagis israel agencies ltd, israel - melphalan - tablets - melphalan 2 mg - melphalan - melphalan - for the treatment of : multiple myeloma and advanced ovarian adenocarcinoma

Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aspen pharma trading ltd. - melphalan 2 mg - tablet - 2 mg - melphalan 2 mg - melphalan

United States - English - NLM (National Library of Medicine)

dr.reddy's laboratories inc - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan 50 mg in 10 ml - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan hydrochloride for injection should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan hydrochloride for injection should not be given the drug.

United States - English - NLM (National Library of Medicine)

generamedix inc. - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan hydrochloride 50 mg in 10 ml - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.

United States - English - NLM (National Library of Medicine)

mylan institutional llc - melphalan hydrochloride (unii: 1vxp4v453t) (melphalan - unii:q41or9510p) - melphalan 50 mg in 10 ml - melphalan hydrochloride for injection is indicated for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate. melphalan should not be used in patients whose disease has demonstrated prior resistance to this agent. patients who have demonstrated hypersensitivity to melphalan should not be given the drug.